The Covid-19 pandemic not only exposed the weaknesses in our healthcare system but also revealed the deep-seated issues that remain prevalent with pharmaceutical companies responsible for developing lifesaving technology. The deep-seated issues pertaining to access to medical resources in third-world countries, where many countries are often left behind in the process of accessing lifesaving technology....